Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Varadhan

Showing results (11-20 of 176) with videos related to

Pageof 18
Sort By:
American Journal of Epidemiology|March 9, 2004
Revealing and addressing length bias and heterogeneous effects in frequency case-crossover studiesRavi Varadhan, Constantine E Frangakis
Journal of Biopharmaceutical Statistics|January 8, 2014
Standardization for subgroup analysis in randomized controlled trialsRavi Varadhan, Sue-Jane Wang
Journal of the American Medical Directors Association|January 11, 2014
What is missing in the validation of frailty instruments?Qian-Li Xue, Ravi Varadhan
JAMA Oncology|September 16, 2021
Is Colorectal Cancer Screening Absolutely Beneficial for Older Adults?Ravi Varadhan, Nancy L Schoenborn
Statistics in Medicine|July 9, 2021
Lasso estimation of hierarchical interactions for analyzing heterogeneity of treatment effectYu Du, Huan Chen, Ravi Varadhan
Demography|April 12, 2017
A Quiescent Phase in Human Mortality? Exploring the Ages of Least VulnerabilityMichal Engelman, Christopher L Seplaki, Ravi Varadhan
Biostatistics (Oxford, England)|August 5, 2023
Identifying predictors of resilience to stressors in single-arm studies of pre-post changeRavi Varadhan, Jiafeng Zhu, Karen Bandeen-Roche
Epidemiologic Methods|January 15, 2021
Modeling of Clinical Phenotypes Assessed at Discrete Study VisitsEmily J Huang, Ravi Varadhan, Michelle C Carlson
Journal of the American Geriatrics Society|May 5, 2018
Can a Link Be Found Between Physical Resilience and Frailty in Older Adults by Studying Dynamical Systems?Ravi Varadhan, Jeremy D Walston, Karen Bandeen-Roche
Annals of Internal Medicine|June 2, 2020
The Predictive Approaches to Treatment effect Heterogeneity (PATH) StatementDavid van Klaveren, Ravi Varadhan, David M Kent
Pageof 18

Showing results (11-20 of 176) with videos related to

Sort By:
Pageof 18
American Journal of Epidemiology|March 9, 2004
Revealing and addressing length bias and heterogeneous effects in frequency case-crossover studiesRavi Varadhan, Constantine E Frangakis
Journal of Biopharmaceutical Statistics|January 8, 2014
Standardization for subgroup analysis in randomized controlled trialsRavi Varadhan, Sue-Jane Wang
Journal of the American Medical Directors Association|January 11, 2014
What is missing in the validation of frailty instruments?Qian-Li Xue, Ravi Varadhan
JAMA Oncology|September 16, 2021
Is Colorectal Cancer Screening Absolutely Beneficial for Older Adults?Ravi Varadhan, Nancy L Schoenborn
Statistics in Medicine|July 9, 2021
Lasso estimation of hierarchical interactions for analyzing heterogeneity of treatment effectYu Du, Huan Chen, Ravi Varadhan
Demography|April 12, 2017
A Quiescent Phase in Human Mortality? Exploring the Ages of Least VulnerabilityMichal Engelman, Christopher L Seplaki, Ravi Varadhan
Biostatistics (Oxford, England)|August 5, 2023
Identifying predictors of resilience to stressors in single-arm studies of pre-post changeRavi Varadhan, Jiafeng Zhu, Karen Bandeen-Roche
Epidemiologic Methods|January 15, 2021
Modeling of Clinical Phenotypes Assessed at Discrete Study VisitsEmily J Huang, Ravi Varadhan, Michelle C Carlson
Journal of the American Geriatrics Society|May 5, 2018
Can a Link Be Found Between Physical Resilience and Frailty in Older Adults by Studying Dynamical Systems?Ravi Varadhan, Jeremy D Walston, Karen Bandeen-Roche
Annals of Internal Medicine|June 2, 2020
The Predictive Approaches to Treatment effect Heterogeneity (PATH) StatementDavid van Klaveren, Ravi Varadhan, David M Kent
Pageof 18